© 2018 The Cochrane Collaboration. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine whether interval brain imaging (performing brain imaging at regular intervals) compared with brain imaging upon clinical indication (performing brain imaging upon the development of new or worsening symptoms) improves outcomes associated with cerebral glioma. To appraise critically and summarise current evidence on the costs and cost-effectiveness of interval brain imaging compared with symptomatic imaging
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compar...
Objectives: At a European Society of Neuroradiology (ESNR) Annual Meeting 2015 workshop, commonaliti...
A recent meeting was held on March 22, 2019, among the U.S. Food and Drug Administration (FDA), clin...
Introduction: Glioblastoma is the most common malignant primary brain tumour with a median overall s...
A recent joint meeting was held on January 30, 2014, with the US Food and Drug Administration (FDA),...
Background Glioblastoma is the most common malignant brain tumor in adults and has a poor prognosis....
Susceptibility-weighted imaging (SWI) is a technique that exploits the susceptibility difference bet...
AIM: To review how machine learning (ML) is applied to imaging biomarkers in neuro-oncology, in part...
Novel analysis techniques were applied to two different sets of multi-modality brain images. Localis...
Background: Following the EuroAIM initiative to assess the quality of medical imaging guidelines by ...
Gliomas are primary brain tumors in adults and are categorized by the World Health Organization (WHO...
Introduction: High-Grade gliomas are the most common form of malignant brain tumours. The incidence ...
© 2018 Dr. Arian LasockiMRI (Magnetic Resonance Imaging), is an integral part of the management of i...
Glioblastoma is the most aggressive of glial tumours in adults. On conventional magnetic resonance (...
Introduction Primary brain tumours, specifically gliomas, are a rare disease group. The disease and ...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compar...
Objectives: At a European Society of Neuroradiology (ESNR) Annual Meeting 2015 workshop, commonaliti...
A recent meeting was held on March 22, 2019, among the U.S. Food and Drug Administration (FDA), clin...
Introduction: Glioblastoma is the most common malignant primary brain tumour with a median overall s...
A recent joint meeting was held on January 30, 2014, with the US Food and Drug Administration (FDA),...
Background Glioblastoma is the most common malignant brain tumor in adults and has a poor prognosis....
Susceptibility-weighted imaging (SWI) is a technique that exploits the susceptibility difference bet...
AIM: To review how machine learning (ML) is applied to imaging biomarkers in neuro-oncology, in part...
Novel analysis techniques were applied to two different sets of multi-modality brain images. Localis...
Background: Following the EuroAIM initiative to assess the quality of medical imaging guidelines by ...
Gliomas are primary brain tumors in adults and are categorized by the World Health Organization (WHO...
Introduction: High-Grade gliomas are the most common form of malignant brain tumours. The incidence ...
© 2018 Dr. Arian LasockiMRI (Magnetic Resonance Imaging), is an integral part of the management of i...
Glioblastoma is the most aggressive of glial tumours in adults. On conventional magnetic resonance (...
Introduction Primary brain tumours, specifically gliomas, are a rare disease group. The disease and ...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compar...
Objectives: At a European Society of Neuroradiology (ESNR) Annual Meeting 2015 workshop, commonaliti...
A recent meeting was held on March 22, 2019, among the U.S. Food and Drug Administration (FDA), clin...